The application relates to an aqueous pharmaceutical formulation comprising 200 - 1000 U/mL [equimolar to 200 - 1000 IU human insulin] of insulin glargine, with the proviso that the concentration of said formulation is not 684 U/mL of insulin glargine, and its use.本案是關於包含200-1000U/mL甘精胰島素[與200-1000IU人類胰島素等莫耳]的水性藥學調配物及其用途,限制條件為該調配物的甘精胰島素濃度不為684U/mL。